Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sabra REIT (SBRA)

Sabra REIT (SBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,012,515
  • Shares Outstanding, K 236,587
  • Annual Sales, $ 647,510 K
  • Annual Income, $ 13,760 K
  • EBIT $ 389 M
  • EBITDA $ 572 M
  • 60-Month Beta 1.24
  • Price/Sales 6.11
  • Price/Cash Flow 19.65
  • Price/Book 1.44

Options Overview Details

View History
  • Implied Volatility 33.54% ( +5.99%)
  • Historical Volatility 24.78%
  • IV Percentile 68%
  • IV Rank 42.20%
  • IV High 70.98% on 06/07/24
  • IV Low 6.20% on 08/15/24
  • Put/Call Vol Ratio 0.48
  • Today's Volume 59
  • Volume Avg (30-Day) 82
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 4,345
  • Open Int (30-Day) 4,023

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.36
  • Number of Estimates 4
  • High Estimate 0.37
  • Low Estimate 0.35
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.53 +2.60%
on 12/20/24
19.20 -11.67%
on 11/29/24
-1.43 (-7.78%)
since 11/20/24
3-Month
16.53 +2.60%
on 12/20/24
20.03 -15.33%
on 11/12/24
-1.68 (-9.01%)
since 09/20/24
52-Week
12.83 +32.19%
on 02/05/24
20.03 -15.33%
on 11/12/24
+2.65 (+18.52%)
since 12/20/23

Most Recent Stories

More News
Sabra: Q3 Earnings Snapshot

Sabra: Q3 Earnings Snapshot

SBRA : 16.96 (+1.37%)
Medical Properties Resumes Control of its Real Estate From Steward

Medical Properties Trust, Inc. MPW — also known as MPT — recently announced that it reached an agreement with Steward Health Care System, its secured lenders and the Unsecured Creditors Committee.This...

SBRA : 16.96 (+1.37%)
MPW : 3.86 (+2.66%)
CTRE : 27.36 (+0.55%)
Sabra: Q2 Earnings Snapshot

Sabra: Q2 Earnings Snapshot

SBRA : 16.96 (+1.37%)
Nursing Home REITs: The Surprise Heroes of High Yield Investing

Income seekers are finding value and yield in nursing home REITs Omega, Sabra and LTC Properties, as they offer stable dividends and tax benefits.

SBRA : 16.96 (+1.37%)
LTC : 35.08 (+0.78%)
OHI : 37.83 (+0.05%)
Sabra Reports First Quarter 2023 Results

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2023.

SBRA : 16.96 (+1.37%)
Sabra Health Care REIT, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 first quarter earnings release on May 3, 2023, after the close of trading.

SBRA : 16.96 (+1.37%)
This Dividend Stock Will Rise by 20%, Per Wall Street. Here's Why You Should Sell It.

Investors will likely be tempted by the high yield, but there's more to the story.

SBRA : 16.96 (+1.37%)
Beware Of These 2 High-Yield Dividend Stocks In 2023

Focus on the drivers that might cause a business to grow, not its dividend yield.

AFCG : 8.97 (+2.87%)
SBRA : 16.96 (+1.37%)
Should You Buy Sabra Health Care REIT for Its 10% Dividend Yield?

The company cut its dividend in 2020 -- could another reduction be inevitable?

SBRA : 16.96 (+1.37%)
Sabra Reports Fourth Quarter 2022 Results

Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2022.

SBRA : 16.96 (+1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in real estate serving the healthcare industry. The trust owns nursing homes, rehabilitation centers, assisted living facilities, and independent living centers. It leases properties to tenants and operators throughout...

See More

Key Turning Points

3rd Resistance Point 17.76
2nd Resistance Point 17.43
1st Resistance Point 17.19
Last Price 16.96
1st Support Level 16.63
2nd Support Level 16.30
3rd Support Level 16.06

See More

52-Week High 20.03
Fibonacci 61.8% 17.28
Last Price 16.96
Fibonacci 50% 16.43
Fibonacci 38.2% 15.58
52-Week Low 12.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar